Navigation Links
2013 NASA Advanced Technology Phase I Concepts Selected For Study
Date:7/19/2013

WASHINGTON, July 19, 2013 /PRNewswire-USNewswire/ -- NASA has selected 12 proposals for study under Phase I of the NASA Innovative Advanced Concepts (NIAC) Program, which aims to turn science fiction into fact.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)

The selected proposals include a wide range of imaginative concepts, including 3-D printing of biomaterials, such as arrays of cells; using galactic rays to map the insides of asteroids; and an "eternal flight" platform that could hover in Earth's atmosphere, potentially providing better imaging, Wi-Fi, power generation, and other applications.

"NASA's Innovative Advanced Concepts Program invites innovators everywhere -- industry, academia, NASA centers, other agencies -- to propose bold, visionary ideas," said Michael Gazarik, NASA's associate administrator for space technology in Washington. "We're working together to transform the future of aerospace while investigating new technologies that may one day benefit our new technology economy and our lives here on Earth."

NASA's Space Technology Mission Directorate chose this year's Phase I proposals based on their potential to transform future aerospace missions by enabling either entirely new missions or breakthroughs in future aerospace capabilities, accelerating progress toward NASA's goals.

NIAC Phase I awards are about $100,000 to conduct nine-month initial definition and analysis studies of a concept. If the basic feasibility studies are successful, proposers can apply for Phase II funding as much as $500,000 for two more years of concept maturation.

"These new Phase I selections include potential breakthroughs for Earth and space science, diverse operations and the potential for new paths that expand human civilization and commerce into space," said NI
'/>"/>

SOURCE NASA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Primary Progression-Free Survival Endpoint Met in Phase III Study of Nintedanib Plus Docetaxel in Second-Line Advanced NSCLC
2. Syngenta Opens Unique $72 Million Advanced Crop Lab
3. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
4. Amphora Research Systems welcomes Advanced Polymer Monitoring Technologies
5. Photonics-Enabled Tools for Forensic Investigations to be Advanced at SPIE DSS
6. Keystone Symposia Announces Grant from Alfred P. Sloan Foundation for an Advanced Life Sciences Training Program
7. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
8. Advanced Animal Diagnostics Raises $6 Million for On-farm Diagnostics
9. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
10. GIN Introduces Advanced Robotics and Dispensing Technology at BVS La Jolla Biotech Day
11. ‘Key’ EUV milestone, DSA progress, more reported at SPIE Advanced Lithography
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... N.J. , March 3, 2015  Regenicin, Inc. ... company specializing in the development of and commercialization of ... tissues and organs, announced today that it has received ... with Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... the Agreement, Amarantus made the final payments due to ...
(Date:3/3/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... Expert Opinion on Biological Therapy , Dr. ... Zhang , at the Henry Ford Hospital in ... 4 (TB4) has the capacity to promote CNS and ... post-injury, leading to neurological recovery in each case.  They ...
(Date:3/3/2015)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... pets, announced today that it will release its fourth quarter ... the market close. The Company will host a conference call ... Interested parties may access the call by dialing toll-free (855) ... conference ID 98449349.  The call will also ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Personalized Medicine - ... , The aim of personalized ... right drug to the right patient and, in ... for a patient according to his/her genotype. This ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3
... Jan. 27 Alfacell Corporation (OTC Bulletin Board: ACEL) ... with the U.S. Food and Drug Administration (FDA) to ... of the ONCONASE rolling New Drug Application (NDA) for ... At the pre-NDA meeting, the FDA provided guidance to ...
... RELY ON INFORMATION PUBLISHED BY UNIVERSAL , NETTLETON, ... Sheets: UBRG) announces that certain unauthorized inaccurate information ... report on BeaconEquity.com website, potentially other websites and ... these materials, the company has found errors in ...
... Webcast Scheduled for Tuesday, February 3, 2009 SAN DIEGO, ... NBIX ) announced today that the Company will report ... the Nasdaq market closes on Tuesday, February 3, 2009. ... webcast to discuss its financial results and provide a ...
Cached Biology Technology:Alfacell Provides ONCONASE(R) NDA Submission Update 2Alfacell Provides ONCONASE(R) NDA Submission Update 3Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results 2
(Date:2/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/sxwl43/global_2d_gesture ) ... 2D Gesture Recognition Market 2015-2019" report to ... the Global 2D Gesture Recognition market to grow ... 2014-2019 The increased demand for gesture-enabled ... the major trends in the market. The growing ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... with intelligence as a beneficial trait, according to ... Medical Center and other institutions. Jeremy Coplan, MD, ... found that high intelligence and worry both correlate ... the nutrient choline in theGlaxoSmithKline Pharmaceuticals, Sackler Institute ...
... Scientists at the Allen Institute for Brain Science have identified ... the brains of human individuals, and between humans and mice ... brain. The study, published online today in the journal ... and also serves as an introduction to what the associated ...
... - - Finger Vein Identity Management ... - - Hitachi Europe Ltd. and M2SYS ... partnership making M2SYS Hitachi,s primary Value Added Reseller in North ... Biometric Finger Vein identity management scanning technology was developed by ...
Cached Biology News:Excessive worrying may have co-evolved with intelligence 2Fine-scale analysis of the human brain yields insight into its distinctive composition 2Fine-scale analysis of the human brain yields insight into its distinctive composition 3M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market 2
Auto/Zyme Reagent...
4',6-Diamidino-2-phenylindole dihydrochloride...
...
Normal Bovine Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin lev...
Biology Products: